15 minutes delayed
Comments
Loading...
KINNATE BIOPHARMA INC COM (NASDAQ:KNTE) Stock, Earnings Estimates, EPS, And Revenue
KINNATE BIOPHARMA INC COM reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 9
EPS
$-0.650
Quarterly Revenue
$0K
Annual Revenue
–
Analyze the earnings history of KINNATE BIOPHARMA INC COM using advanced sorting and filters.
Data brought to you by Benzinga APIs
KINNATE BIOPHARMA INC COM (KNTE) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2023 | 2023-11-09 | $-0.65 | $-0.67 | 2.99 % |
| Jun 2023 | 2023-08-08 | $-0.68 | $-0.75 | 9.33 % |
| Mar 2023 | 2023-05-11 | $-0.73 | $-0.73 | 0.00 % |
| Dec 2022 | 2023-03-15 | $-0.72 | $-0.72 | 0.00 % |
KINNATE BIOPHARMA INC COM (KNTE) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is KINNATE BIOPHARMA INC COM (NASDAQ:KNTE) reporting earnings?
KINNATE BIOPHARMA INC COM (KNTE) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on November 9, 2023 for Q3.
What were the latest earnings per share (EPS) for KINNATE BIOPHARMA INC COM (NASDAQ:KNTE)?
The Actual EPS was $-0.65, which beat the estimate of $-0.67.
What were KINNATE BIOPHARMA INC COM’s (NASDAQ:KNTE) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.